{"url":"https://lda.senate.gov/api/v1/filings/d99a5adb-8a6d-4e8a-874d-0e8063fc33f2/","filing_uuid":"d99a5adb-8a6d-4e8a-874d-0e8063fc33f2","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2008,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d99a5adb-8a6d-4e8a-874d-0e8063fc33f2/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ryan D. Israel, Attorney","dt_posted":"2009-01-21T18:16:36-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1301 Pennsylvania Ave., NW","registrant_address_2":"Suite 500","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":7565,"url":"https://lda.senate.gov/api/v1/registrants/7565/","house_registrant_id":32403,"name":"BUTERA & ANDREWS","description":"Law/Lobbying Firm","address_1":"1301 Pennsylvania Ave., NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RYAN ISRAEL","contact_telephone":"+1 202-203-1020","dt_updated":"2022-04-06T16:07:14.715534-04:00"},"client":{"id":110837,"url":"https://lda.senate.gov/api/v1/clients/110837/","client_id":1038,"name":"DESTINATION RX INC","general_description":null,"client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Operation of the Medicare Part D prescription drug insurance program and related pharmaceutical assistance programs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25244,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"J","last_name":"BUTERA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":4754,"prefix":"mr","prefix_display":"MR.","first_name":"RYAN","nickname":null,"middle_name":"D","last_name":"ISRAEL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}